无创高频振荡通气联合肺表面活性物质在低出生体重呼吸窘迫综合征早产儿治疗中的应用价值
2025-08-09黄灿星
Application Value of Non-invasive High Frequency Oscillatory Ventilation Combined with Pulmonary Surfactant inthe TreatmentofLow BirthWeightPremature Infants withRespiratoryDistress Syndrome/ HUANG Canxing.//Medical Innovation of China,2025,22(16): 034-038
[Abstract]Objective: To investigate the clinical effect of non-invasive high frequencyoscilatory ventilation (NHFOV) combined with pulmonary surfactant (PS)in low birth weight premature infants with respiratory distress syndrome.Method:A total of 84 lowbirth weight premature infants with respiratory distress syndrome admitted to LongyanPeople's Hospital from May2O21 to October 2O24 wereselectedand divided into two groups according to therandom number table method,with 42 cases ineach group.Both groups were treated with PS.The control group received nasal continuous positive airway pressure (NCPAP) treatment,and the observation group received NHFOV treatment.The blood gas analysis related indicators,invasive mechanical ventilation conditions,inflammatory factors levels and the occurrence of complications were compared between the two groups.Result: There were no significant difference inblood gasanalysisrelated indicators between the two groups before treatment (Pgt;0.05 .Comparedwiththe control group,the arterial partial pressure ofcarbon dioxide (PaCO2) after 24 hours of treatment in the observation group was lower,and the arterial partial pressure of oxygen/fraction of inspired oxygen ( PaO2/FiO2 was higher,the differences were statistically significant ( P lt;0.05).After24 hours of treatment, there was no statistically significant difference in pH value between the two groups (Pgt;O.05).The invasive mechanical ventilation rate in the control group (21.43 % 9/42) was higher than that in the observation group (4.76 % , 2/42), the difference was statistically significant ( P lt;0.05). There were no statistically significant differences in the levels of transforming growth factor- β1 (TGF- β 1) and high mobility box B1 (HMGB1) between the two groups before treatment and after 24 hours of treatment ( Pgt; 0.05). There was no significant difference in the incidence of complications between the two groups ( Pgt;0.05 ).Conclusion:Low birth weight premature infants with respiratory distress syndrome who receive treatment with NHFOV combined with PS canefectivelyimprovebloodgasindicators,reducetherateofinvasive mechanicalentilation,ndwillnotagravate the inflammatory response and increase the occurrence of mechanical ventilator-related complications.
[Key Words] Low birth weight Respiratory distress syndromePremature infantsNon-invasive high frequency oscillatory ventilationPulmonary surfactantBlood gas analysisMechanical ventilation Inflammatory factors
First-author'saddres:DepartmentofNeonatal,LongyanPeople'sHospital,Longyan364ooo,China doi:10.3969/j.issn.1674-4985.2025.16.009
呼吸窘迫综合征作为一种严重呼吸系统疾病,在早产儿中较为常见,尤其是低出生体重儿,其发病主要原因在于肺表面活性物质(PS)缺乏,患儿表现为肺泡萎陷、肺顺应性下降等,极易引发呼吸困难、吸气性凹陷等,严重者甚至危及生命[1-2]PS是一种复合物质,由磷脂和特定蛋白质组成,覆盖在肺泡表面,减小肺泡表面张力,确保肺泡在呼气末时依然保持扩张状态而不易塌陷,从而在整个呼吸循环中维持高效的气体交换过程[3-4]。经鼻持续气道正压通气(NCPAP)是改善呼吸窘迫综合征患儿呼吸的传统辅助通气方法,通过给予恒定气道正压帮助保持肺部通气和预防肺泡塌陷,但有一定局限性,对于高碳酸血症患儿,可能无法提供足够通气支持,导致治疗无效或需转为其他形式的通气支持[5。无创高频振荡通气(NHFOV)是一种新型辅助通气模式,通过面罩、鼻塞或鼻导管将振荡压力波作用于肺部,以高频、低潮气量方式提供通气支持,不仅能改善肺泡扩张状况及肺部气体交换功能,还可降低呼吸机相关性肺损伤风险。基于此,本研究选择2021年5月—2024年10月龙岩人民医院收治的低出生体重呼吸窘迫综合征早产儿84例,分析NHFOV联合PS治疗的临床效果,报道如下。
1资料与方法
1.1一般资料
选择2021年5月—2024年10月本院收治的低出生体重呼吸窘迫综合征早产儿84例。(1)纳入标准:胎龄 ⩽36 周,出生体重 lt;2500g 且 ⩾1500g 符合文献[7]《实用新生儿学》中呼吸窘迫综合征诊断;对PS耐受。(2)排除标准:存在感染性疾病;存在自身免疫性疾病;……
